Zobrazeno 1 - 10
of 188
pro vyhledávání: '"Tadao Ohno"'
Autor:
Katsuhiko Fukuda, Tadao Ohno
Publikováno v:
Clinical Case Reports, Vol 11, Iss 6, Pp n/a-n/a (2023)
Key Clinical Message To overcome patient‐initiated treatment refusal because of fear of experiencing severe negative adverse events, mild immunotherapy using a cancer vaccine such as the autologous formalin‐fixed tumor vaccine should be considere
Externí odkaz:
https://doaj.org/article/52412b2b6c0f4144b354b51e559f1cbc
Publikováno v:
World Journal of Surgical Oncology, Vol 15, Iss 1, Pp 1-6 (2017)
Abstract Background The prognosis of advanced (stage IV) cancer of the digestive organs is very poor. We have previously reported a case of advanced breast cancer with bone metastasis that was successfully treated with combined treatments including a
Externí odkaz:
https://doaj.org/article/02ddbd19dd09495384bcf06695af9a1c
Autor:
Fumito Kuranishi, Yuki Imaoka, Yuusuke Sumi, Yoji Uemae, Hiroko Yasuda-Kurihara, Takeshi Ishihara, Tsubasa Miyazaki, Tadao Ohno
Publikováno v:
International Journal of Breast Cancer, Vol 2018 (2018)
Introduction. No effective treatment has been developed for bone-metastatic breast cancer. We found 3 cases with clinical complete response (cCR) of the bone metastasis and longer overall survival of the retrospectively examined cohort treated compre
Externí odkaz:
https://doaj.org/article/9cbfee63ad364b988cef2c5c510d1602
Autor:
Yoshihiro Muragaki, Eiichi Ishikawa, Takashi Maruyama, Masayuki Nitta, Taiichi Saito, Soko Ikuta, Takashi Komori, Takakazu Kawamata, Tetsuya Yamamoto, Koji Tsuboi, Akira Matsumura, Hideo Nakamura, Junichiro Kuroda, Tatsuya Abe, Yasutomo Momii, Ryuta Saito, Teiji Tominaga, Yusuke Tabei, Ichiro Suzuki, Yoshiki Arakawa, Susumu Miyamoto, Masao Matsutani, Katsuyuki Karasawa, Yoichi Nakazato, Katsuya Maebayashi, Koichi Hashimoto, Tadao Ohno
Publikováno v:
Journal of Neurosurgery. :1-11
OBJECTIVE An autologous formalin-fixed tumor vaccine (AFTV) derived from resected glioblastoma (GBM) tissue can be used against unidentified tumor antigens. Thus, the authors conducted a multicenter double-blind phase IIb trial to investigate the eff
Publikováno v:
Acta Biomaterialia. 145:235-245
Immune checkpoint inhibitors elicit durable tumor regression in multiple types of tumor, but may induce potential side effects with low response rates in many tumors. Herein, to increase the therapeutic efficacy of immune checkpoint inhibitors, a hol
Autor:
Katsuhiko Fukuda, Tadao Ohno
A patient with stage IV uterine cancer displaying circulating tumor cells and high microsatellite instability who had rejected standard chemotherapy and immune-check-point inhibitor treatment received monotherapy with autologous formalin-fixed tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::733261c9d4f05f9fda9945b90726ba8d
https://doi.org/10.22541/au.164933838.83663892/v1
https://doi.org/10.22541/au.164933838.83663892/v1
Publikováno v:
SSRN Electronic Journal.
Autor:
Atsushi Yamazaki, Yu Sogo, Kaoru Hashimoto, Tadao Ohno, Xia Li, Atsuo Ito, Xiupeng Wang, Yohei Watanabe, Noriko M. Tsuji
Publikováno v:
Chemical Communications. 54:1057-1060
Stellated fibrous mesoporous silica nanospheres significantly improve the cellular uptake of cancer antigen and the maturation of bone marrow derived dendritic cells in vitro. Moreover, the combination of poly(I:C) with stellated fibrous MS nanospher
Autor:
Yuki Imaoka, Yuusuke Sumi, Fumito Kuranishi, Yoji Uemae, Tadao Ohno, Hiroko Yasuda-Kurihara, Tsubasa Miyazaki, Takeshi Ishihara
Publikováno v:
International Journal of Breast Cancer
International Journal of Breast Cancer, Vol 2018 (2018)
International Journal of Breast Cancer, Vol 2018 (2018)
Introduction. No effective treatment has been developed for bone-metastatic breast cancer. We found 3 cases with clinical complete response (cCR) of the bone metastasis and longer overall survival of the retrospectively examined cohort treated compre
Autor:
Takakazu Kawamata, Manabu Tamura, Taiichi Saito, Eiichi Ishikawa, Tadao Ohno, Shunichi Tsuzuki, Yoshihiro Muragaki, Masayuki Nitta, Atsushi Fukui
Publikováno v:
Neuro-Oncology Advances. 3:iv5-iv5
INTRODUCTION The development of novel treatments for glioblastoma is desired and immunotherapy is theoretically expected for highly invasive glioblastoma. An autologous formalin-fixed vaccine (AFTV) derived from resected tumor tissue is stable, conta